Peripheral Administration of GSK-3β Antisense Oligonucleotide Improves Learning and Memory in SAMP8 and Tg2576 Mouse Models of Alzheimer's Disease. (Q48469041)

From Wikidata

Jump to navigation Jump to search

scientific article published on 31 August 2016

Language	Label	Description	Also known as
English	Peripheral Administration of GSK-3β Antisense Oligonucleotide Improves Learning and Memory in SAMP8 and Tg2576 Mouse Models of Alzheimer's Disease.	scientific article published on 31 August 2016

Statements

scholarly article

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/27589526

Peripheral Administration of GSK-3β Antisense Oligonucleotide Improves Learning and Memory in SAMP8 and Tg2576 Mouse Models of Alzheimer's Disease. (English)

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/27589526

Alzheimer's disease

0 references

author name string

Susan A Farr

1

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/27589526

Karin E Sandoval

2

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/27589526

Michael L Niehoff

3

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/27589526

Ken A Witt

4

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/27589526

Vijaya B Kumar

5

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/27589526

John E Morley

6

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/27589526

publication date

31 August 2016

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/27589526

Journal of Alzheimer's Disease

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/27589526

54

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/27589526

1339-1348

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/27589526

4

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/27589526

GSK-3: Functional Insights from Cell Biology and Animal Models

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160416

21 January 2018

The GSK3 hypothesis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160416

21 January 2018

Glycogen synthase kinase 3 inhibitors in the next horizon for Alzheimer's disease treatment

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160416

21 January 2018

Glycogen synthase kinase-3: a potential preventive target for prostate cancer management

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160416

21 January 2018

Potential application of lithium in Parkinson's and other neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160416

21 January 2018

Neuroprotective effects of lithium: implications for the treatment of Alzheimer's disease and related neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160416

21 January 2018

Understanding the relationship between GSK-3 and Alzheimer's disease: a focus on how GSK-3 can modulate synaptic plasticity processes

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160416

21 January 2018

PP2A regulates tau phosphorylation directly and also indirectly via activating GSK-3beta

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160416

21 January 2018

Learning and memory in the SAMP8 mouse

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160416

21 January 2018

Beta-amyloid precursor polypeptide in SAMP8 mice affects learning and memory.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160416

21 January 2018

Quantitative proteomics analysis of specific protein expression and oxidative modification in aged senescence-accelerated-prone 8 mice brain

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160416

21 January 2018

Antisense oligonucleotide against GSK-3β in brain of SAMP8 mice improves learning and memory and decreases oxidative stress: Involvement of transcription factor Nrf2 and implications for Alzheimer disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160416

21 January 2018

Activation of Akt by lithium: pro-survival pathways in aging.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160416

21 January 2018

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160416

21 January 2018

Propranolol reduces cognitive deficits, amyloid and tau pathology in Alzheimer's transgenic mice.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160416

21 January 2018

Tau immunotherapy modulates both pathological tau and upstream amyloid pathology in an Alzheimer's disease mouse model.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160416

21 January 2018

On the delay-dependent involvement of the hippocampus in object recognition memory.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160416

21 January 2018

Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160416

21 January 2018

Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPK) I/glycogen synthase kinase-3 beta and cyclin-dependent kinase 5, a component of TPK II.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160416

21 January 2018

Lithium reduces tau phosphorylation by inhibition of glycogen synthase kinase-3.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160416

21 January 2018

Chronic lithium administration to FTDP-17 tau and GSK-3beta overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre-formed neurofibrillary tangles do not revert.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160416

21 January 2018

Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160416

21 January 2018

Increased level of active GSK-3beta in Alzheimer's disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160416

21 January 2018

Lithium improves hippocampal neurogenesis, neuropathology and cognitive functions in APP mutant mice

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160416

21 January 2018

Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160416

21 January 2018

Distribution of active glycogen synthase kinase 3beta (GSK-3beta) in brains staged for Alzheimer disease neurofibrillary changes.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160416

21 January 2018

Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160416

21 January 2018

Hyperphosphorylation of Tau at Ser396 occurs in the much earlier stage than appearance of learning and memory disorders in 5XFAD mice.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160416

21 January 2018

SAMP8 mice have altered hippocampal gene expression in long term potentiation, phosphatidylinositol signaling, and endocytosis pathways

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160416

21 January 2018

Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160416

21 January 2018

Antisense oligonucleotides in therapy for neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160416

21 January 2018

Next generation antithrombotic therapy: focus on antisense therapy against coagulation factor XI.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160416

21 January 2018

Antisense oligonucleotides, microRNAs, and antibodies.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160416

21 January 2018

Identifiers

10.3233/JAD-160416

0 references

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/27589526

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48469041&oldid=818433201"